Home Search Abstracts Browse Oral Sessions Browse Poster Sessions Webcasts and Podcasts

 

Session 100  Poster Abstracts
Therapeutic Drug Monitoring
Wednesday, 1:30 - 3:30 pm
Poster Hall
      589 Improved ART Exposure with Therapeutic Drug Monitoring
Brookie Best*1, M Witt2, M Goicoechea1, C Kemper3, R Larsen4, C Diamond5, E Capparelli1, G Wagner6, J McCutchan1, and R Haubrich1
1Univ of California, San Diego, US; 2Harbor-Univ of California, Los Angeles, Torrance, US; 3Santa Clara Valley Med Ctr, San Jose, CA, US; 4David Geffen Sch of Med, Univ of California, Los Angeles Med Ctr, US; 5Univ of California Sch of Med, Irvine, US; and 6Rand, Santa Monica, CA, US
      590

White Coat Compliance Patterns Make Therapeutic Drug Monitoring a Potentially Unreliable Tool for Assessing Long-term Drug Exposure
Thomas J Podsadecki*1, B Vrijens2, E Tousset2, R Rode1, and G Hanna1
1Abbott Labs, Abbott Park, IL, US and 2AARDEX Ltd, Zug, Switzerland
      591 Therapeutic Drug Monitoring of Boosted Tipranavir with and without Combination to Lopinavir or Fosamprenavir
Gilles Peytavin*1, A Marcelin2, A Rouault1, M Bonmarchand2, H Aït-Mohand2, B Cassard1, L Schneider2, D Costagliola3, V Calvez2, and C Katlama2
1Hosp Bichat, Paris, France; 2Hosp Pitié-Salpétrière, Paris, France; and 3INSERM EMI 0214, Paris, France
      592 Identification and Quantification of Factors Influencing Antiretroviral Exposure in a Diverse Population
Monica Gandhi*1, A Kalinowski1, P Bacchetti1, M Cohen2, M Young3, K Anastos4, S Holman5, A Levine6, R Greenblatt1, and Women's Interagency HIV Study
1Univ of California, San Francisco, US; 2Rush Med Coll, Chicago, IL, US; 3Georgetown Univ, Washington, DC, US; 4Lincoln Med and Mental Hlth Ctr, Bronx, NY, US; 5State Univ of New York, Brooklyn, US; and 6Univ of Southern California, Los Angeles, US
      593

Novel Method for ART Quantitation in the Female Genital Tract
Chantelle Bennetto*1, V Johnson1,2, J King1, and E Acosta1
1Univ of Alabama at Birmingham Sch of Med, US and 2VAMC, Birmingham, Alabama, US
      594 Different Methods to Calculate the Inhibitory Quotient of Boosted Single-protease Inhibitors and Their Association with Virological Response
A Winston1, N Patel1, D Back2, S Khoo2, S Bulbeck1, A Pozniak1, M Nelson1, G Moyle1, B Gazzard1, and Marta Boffito*1
1Chelsea and Westminster Hosp, London, UK and 2Univ of Liverpool, UK